Form 4 Filing for IMMUNIC, INC.

This filing details a Form 4 submission for IMMUNIC, INC. (IMUX) on June 29, 2026. Richard Alan Rudick, a director, was granted 25,370 stock options with a purchase price of $0.00, exercisable at $10.90 per share. These options, conditionally approved on March 27, 2026, are subject to stockholder approval of an amendment to the Company's 2019 Omnibus Equity Incentive Plan, which was obtained at the 2026 Annual Meeting of Stockholders. The options are fully vested as of March 27, 2026, and are set to expire on March 27, 2036. The underlying security is Common Stock. Following this transaction, Mr. Rudick holds 25,370 shares.